USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
13 Oct 2022 | 02:45 PM GMT

The Use of New Technologies to Improve Clinical Trial Operational Efficiency

Anchored by:

Matthew Wilson
CEO
UMED TECHNOLOGIES

Participants:

Matthew Wilson CEOuMed Technologies
Matthew Wilson
CEOuMed Technologies
Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Rooshil Shah Strategy and FinanceRedesign Health
Rooshil Shah
Strategy and FinanceRedesign Health
Steffanie Bristol Head, Biogen Digital Health VenturesBiogen
Steffanie Bristol
Head, Biogen Digital Health VenturesBiogen
Tanja Dowe Managing DirectorAngelini Ventures
Tanja Dowe
Managing DirectorAngelini Ventures

About this Meeting

Clinical trials are thoughtfully designed and implemented to ensure the right patients are involved, quality standards are strictly followed, and the endpoints selected are the right ones to show the drug’s safety and effectiveness. Running traditional trials is expensive and time-consuming and new technologies have an enormous potential to increase clinical trials' operational efficiency. While technology in clinical trials has been discussed for a while, the industry still needs to figure out how to successfully adopt them.    

Do you want to know more about how to use new technologies to improve clinical trials operational efficiency? Join this session to discuss the following: 
  • Recruiting the right patients is essential but most trials fail to enrol or under enrol. What are the challenges in patient recruitment and diversity that can be overcome using new technologies? How to use these technologies successfully?  
  • In a trial, patient retention is key to success. How can new technologies help retain patients?  
  • Site selection and activation is one of the key drivers for patient recruitment. Are there any new technologies that can help improve site selection and activation?  
  • RPM is more cost-effective than on-site monitoring and less demanding for participants. While using digital solutions as trial endpoints can be very challenging, RPM could still be useful to track treatment compliance or safety. How can RPM help improve clinical trials operations, beyond the possibility to use them as endpoints? How to make sure these solutions integrate efficiently into the trial protocol and the day-to-day operations?